ACS CAN Comments on Prior Authorization Proposed Rule
March 18, 2023
ACS CAN offered comments on the Patient Access Application Programing Interface (API) and the requirements to improve the prior authorization process. We support many of the proposals to improve the prior authorization process, but urge HHS to include prescription drugs both in the Patient Access API and the improvements to the prior authorization processes because prescription drugs are often a critical component of cancer care.
Specific areas on which we commented:
- Patient Access Application Programing Interface (API)
- Improving Prior Authorization Processes
- Accelerating the Adoption of Standards Related to Social Risk Factor Data